Pharmaceutical Companies: R&D Reimagined
Vital Use Case: Accelerating drug discovery through "Gold Standard" longitudinal data. Access real-world evidence (RWE) to study long-term treatment outcomes and patient adherence without the cost of traditional phase IV trials.
Type-2 Diabetic patients (Age 45-60) in Urban India with 12+ months of unbroken glucose and activity logs.
Pharmaceutical partners can support preventive health initiatives, early disease detection campaigns, and therapy adherence programs while generating valuable real-world health insights across rural and semi-urban populations. This collaboration creates a powerful bridge between pharma innovation and community healthcare delivery, ensuring that life-saving therapies reach patients earlier and more effectively.
Buyer Deliverables
Research Dashboard
Visualized patient journey trends and anomaly detection.
Secure API
Exportable, anonymized CSV/JSON datasets compatible with R and Python analysis tools.